| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b94e8ed234ad484c5475ddd7b91302f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b4ee13af463c18c765406625e1c5d44 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-56341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2503-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2503-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-48 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-563 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B6-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 |
| filingDate |
2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a86f25a87178cc4844f2508d531abb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90dc010510ef6d566e3b710bbb59c4c0 |
| publicationDate |
2020-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10827946-B2 |
| titleOfInvention |
Fractional anisotropy in MRI as an indicator of reversible pathology |
| abstract |
The present invention concerns a method for determining whether brain regions of interest having reversible or irreversible pathology. The method includes acquiring over a predetermined period of time a plurality of magnetic resonance imaging (MRI) images for each brain region of interest; analyzing the MRI images to obtain quantitative measurements of the fractional anisotropy (FA) for each brain region of interest and determining that brain regions of interest have reversible pathology when the measured FA increases and then decreases over the predetermined period of time. |
| priorityDate |
2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |